HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Acquati Selected Research

human RNASET2 protein

10/2020Expression and purification of the human tumor suppressor protein RNASET2 in CHO-S cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Acquati Research Topics

Disease

14Neoplasms (Cancer)
10/2020 - 10/2003
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2008
2Necrosis
01/2022 - 08/2004
2Hypoxia (Hypoxemia)
07/2021 - 01/2021
2Bacterial Infections (Bacterial Infection)
06/2020 - 01/2019
2Carcinoma (Carcinomatosis)
02/2019 - 10/2003
2Ovarian Neoplasms (Ovarian Cancer)
12/2016 - 06/2011
2Carcinogenesis
05/2013 - 05/2005
1Whooping Cough (Pertussis)
01/2022
1Diphtheria
01/2022
1Tetanus
01/2022
1Dementia (Dementias)
01/2022
1Proteostasis Deficiencies
01/2022
1Wounds and Injuries (Trauma)
01/2021
1Infections
01/2020
1Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
01/2019
1Adenocarcinoma
01/2019
1Lymphoma (Lymphomas)
09/2012
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2012
1Vesicular Stomatitis
01/2012
1Congenital Heart Defects (Congenital Heart Defect)
08/2009
1Breast Neoplasms (Breast Cancer)
04/2009
1Nonaka type Distal myopathy
11/2008
1Inclusion Body Myositis
11/2008
1Neoplasm Metastasis (Metastasis)
05/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2003
1Chromosome Aberrations (Chromosome Abnormalities)
10/2003

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2008
7Ribonucleases (Ribonuclease)IBA
01/2020 - 05/2005
4Biological ProductsIBA
01/2021 - 11/2008
3ribonuclease T(2)IBA
01/2018 - 09/2012
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 11/2008
2AlarminsIBA
10/2020 - 01/2019
2Messenger RNA (mRNA)IBA
01/2019 - 08/2009
2EnzymesIBA
12/2016 - 11/2008
1Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2022
1Amyloidogenic ProteinsIBA
01/2022
1LigandsIBA
07/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1cobaltous chloride (cobalt(II)chloride)IBA
01/2021
1human RNASET2 proteinIBA
10/2020
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
10/2020
1MicroRNAs (MicroRNA)IBA
12/2016
1Recombinant ProteinsIBA
06/2015
1lipid phosphate phosphataseIBA
09/2012
1AutoantigensIBA
09/2012
1Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA
09/2012
1Anaplastic Lymphoma KinaseIBA
09/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2012
1Glycoproteins (Glycoprotein)IBA
01/2012
1AgarIBA
06/2011
1Sodium Glutamate (Accent)IBA
01/2011
1Antisense RNA (Anti-Sense RNA)IBA
04/2009
1Peptide Hydrolases (Proteases)FDA Link
11/2008
1Styrene (Styrol)IBA
08/2004
1MetalsIBA
10/2003
1PlatinumIBA
10/2003
1IonsIBA
10/2003
1CadmiumIBA
10/2003
1Genetic Markers (Genetic Marker)IBA
10/2003

Therapy/Procedure

1Investigational Therapies (Experimental Therapy)
01/2022
1Therapeutics
01/2019